Skip to main content
. 2015 Oct 30;2015(10):CD000067. doi: 10.1002/14651858.CD000067.pub3

Comparison 4. Azathioprine + infliximab versus infliximab.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Maintenance of remission 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
2 Adverse events 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
3 Withdrawals due to adverse events 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
4 Serious adverse events 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected